Metabolic impact of low dose IL-2 therapy for primary Sjögren's Syndrome in a double-blind, randomized clinical trial.
Saved in:
| Title: | Metabolic impact of low dose IL-2 therapy for primary Sjögren's Syndrome in a double-blind, randomized clinical trial. |
|---|---|
| Authors: | Feng, Ruiling1 (AUTHOR), Xiao, Xian1 (AUTHOR), Wang, Yifan1 (AUTHOR), Huang, Bo1 (AUTHOR), Chen, Jiali1 (AUTHOR), Cheng, Gong1 (AUTHOR), Jin, Yuebo1 (AUTHOR) xianglifuer@163.com |
| Source: | Clinical Rheumatology. Dec2024, Vol. 43 Issue 12, p3789-3798. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
